Andrew Callos - 02 Mar 2022 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
EVP, Chief Commercial Officer
Signature
By: Robert Wong For: Andrew Callos
Issuer symbol
CYTK
Transactions as of
02 Mar 2022
Transactions value $
$1,693,350
Form type
4
Filing time
03 Mar 2022, 15:39:19 UTC
Previous filing
17 Feb 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Award $0 +20K +322.79% $0.00 26.2K 02 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Incentive Stock Option (right to buy) Award $500K +13.3K $37.63 13.3K 02 Mar 2022 Common Stock 13.3K $37.63 Direct F2
transaction CYTK Non-Qualified Stock Option (right to buy) Award $1.19M +31.7K $37.63 31.7K 02 Mar 2022 Common Stock 31.7K $37.63 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Comprised of restricted stock units that will vest over 3 years, with 40% vesting on the 1-year anniversary of the grant, an additional 40% vesting on the 2-year anniversary of the grant, and the final 20% vesting on the 3-year anniversary of the grant.
F2 This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant.